We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Medicine man

21 January 2011 By Antony Currie

The Charlottebased bank’s stock has lagged major rivals as crisis concerns linger. Meanwhile fellow TARP doubledipper Citi rebounded as its restructuring took hold. If BofA boss Moynihan can convince investors it has taken the same medicine, its stock should recover.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)